Skip to main content

Table 2 Multivariable logistic regression for analyzing the bone metastases associated factors in different histological types of lung cancer

From: Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer

Variable

Patients, N.

Entire cohort

No Bone metastasis N (%)

Bone metastasis N (%)

Adenocarcinoma

Squamous

SCLC

LC

NSCLC/NOS

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

Sex

 Female

46,496 (47.8)

10,752 (41.9)

ref

1.0

ref

1.0

ref

1.0

ref

1.0

ref

1.0

 Male

50,750 (52.2)

14,893 (58.1)

1.24 (1.15–1.34)

< 0.001

1.32 (1.15–1.51)

< 0.001

1.33 (1.23–1.45)

< 0.001

1.32 (1.01–1.72)

0.042

1.37 (1.21–1.55)

< 0.001

Metastatic sites

 0 site

71,363 (73.3)

10,192 (40.0)

ref

1.0

ref

1.0

ref

1.0

ref

1.0

ref

1.0

 1 site

21,085 (21.7)

10,071 (39.6)

3.39 (3.11–3.70)

< 0.001

3.98 (3.47–4.57)

< 0.001

2.95 (2.69–3.23)

< 0.001

2.87 (2.16–3.81)

< 0.001

3.34 (1.91–3.82)

< 0.00`

 2 sites

4339 (4.5)

4331 (17.0)

6.47 (5.68–7.36)

< 0.001

8.22 (6.40–10.54)

< 0.001

5.55 (4.89–6.30)

< 0.001

6.23 (4.22–9.21)

< 0.001

5.29 (4.34–6.45)

< 0.001

 3 sites

439 (0.5)

868 (3.4)

12.08 (8.65–16.87)

< 0.001

13.64 (7.73–24.08)

< 0.001

7.57 (5.57–10.29)

< 0.001

5.97 (2.02–17.62)

0.001

10.38 (6.73–16.01)

< 0.001

Tumor size

  < 2 cm

14,785 (17.7)

1996 (10.0)

ref

1.0

ref

1.0

ref

1.0

ref

1.0

ref

1.0

 2–5 cm

41,463 (49.7)

10,122 (51.0)

1.83 (1.60–2.11)

< 0.001

1.66 (1.23–2.25)

0.001

1.42 (1.22–1.65)

< 0.001

1.28 (0.82–2.00)

0.28

NS

NS

 5–10 cm

23,894 (28.7)

6859 (34.6)

1.99 (1.72–2.31)

< 0.001

1.95 (1.44–2.64)

< 0.001

1.38 (1.19–1.61)

< 0.001

1.52 (0.97–2.40)

0.07

NS

NS

  > 10 cm

3210 (3.9)

875 (4.4)

1.55 (1.21–2.00)

< 0.001

1.86 (1.26–2.73)

< 0.001

1.35 (1.10–1.66)

0.004

1.61 (0.87–2.97)

0.13

NS

NS

Histological type

 Well differentiated

6441 (11.8)

372 (4.1)

ref

1.0

ref

1.0

ref

1.0

ref

1.0

ref

1.0

 Moderate differentiated

18,285 (33.4)

2149 (23.6)

1.49 (1.27–1.75)

< 0.001

0.81 (0.53–1.22)

0.31

NS

NS

NS

NS

2.31 (1.61–3.32)

< 0.001

 Poor differentiated

26,632 (48.7)

5681 (62.4)

1.52 (1.30–1.78)

< 0.001

1.26 (0.84–1.88)

0.27

NS

NS

NS

NS

4.65 (3.36–6.42)

< 0.001

 Undifferentiated

3315 (6.1)

909 (10.0)

1.80 (1.24–2.62)

< 0.001

2.05 (1.07–3.92)

0.03

NS

NS

NS

NS

4.56 (3.10–6.70)

< 0.001

Lymphatic metastasis

 N0

38,449 (40.4)

4325 (17.8)

ref

1.0

ref

1.0

ref

1.0

ref

1.0

ref

1.0

 N1

8708 (9.2)

1985 (8.2)

1.77 (1.53–2.05)

< 0.001

1.82 (1.45–2.29)

< 0.001

1.30 (1.06–1.61)

0.013

2.29 (1.41–3.70)

0.001

1.99 (1.59–2.50)

< 0.001

 N2

35,358 (37.2)

12,297 (50.6)

3.39 (3.07–3.75)

< 0.001

3.07 (2.61–3.61)

< 0.001

1.85 (1.60–2.13)

< 0.001

2.89 (2.05–4.08)

< 0.001

2.39 (2.04–2.80)

< 0.001

 N3

12,635 (13.3)

5682 (23.4)

3.92 (3.46–4.45)

< 0.001

3.23 (2.62–3.99)

< 0.001

2.56 (2.20–2.99)

< 0.001

2.94 (1.94–4.45)

< 0.001

2.96 (2.43–3.61)

< 0.001

  1. SCLC small cell lung cancer, LC large cell, NOS not otherwise specified, NSCLC non-small cell lung cancer, NS not significant